New Zealand markets open in 6 hours 54 minutes

Lixte Biotechnology Holdings, Inc. (LIXT)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
2.88000.0000 (0.00%)
As of 11:03AM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 6.43M
Enterprise value 5.73M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)13.00
Enterprise value/revenue N/A
Enterprise value/EBITDA -1.13

Trading information

Stock price history

Beta (5Y monthly) -0.29
52-week change 3-47.64%
S&P500 52-week change 323.57%
52-week high 39.5000
52-week low 31.5800
50-day moving average 32.8508
200-day moving average 32.6067

Share statistics

Avg vol (3-month) 3581.46k
Avg vol (10-day) 315.9k
Shares outstanding 52.25M
Implied shares outstanding 62.25M
Float 81.98M
% held by insiders 120.48%
% held by institutions 15.08%
Shares short (15 Apr 2024) 482.65k
Short ratio (15 Apr 2024) 40.05
Short % of float (15 Apr 2024) 43.77%
Short % of shares outstanding (15 Apr 2024) 43.67%
Shares short (prior month 15 Mar 2024) 419.57k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 320 Nov 2020
Ex-dividend date 4N/A
Last split factor 21:10
Last split date 305 Jun 2023

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-64.47%
Return on equity (ttm)-111.07%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA N/A
Net income avi to common (ttm)-5.09M
Diluted EPS (ttm)-2.6600
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)4.2M
Total cash per share (mrq)1.87
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)13.73
Book value per share (mrq)0.22

Cash flow statement

Operating cash flow (ttm)-4.29M
Levered free cash flow (ttm)-2.4M